Forecast & Rating19 analysts currently cover SKB BIO, with about 100.0% giving a positive rating — meaning they expect the stock to rise. The average price target is HK$618.43, about 20.2% upside from the current price of HK$514.50. Price targets span a fair range, indicating some disagreement among institutions. Historically, about 100.0% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study SKB BIO closely still see room for the stock to rise. Data as of Aug 28, 2026; for reference only and not investment advice.
Aug 25, 2026Price forecast
HK$618.4320.20%
Forecast & RatingStrong buy
19analysts
- Strong buy84.21%
- Buy15.79%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateAug 23, 2026
Forecast met86.9%
Stock price$514.50
Avg. target$532.6
High target$593
Low target$434
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.